In Memoriam

Remembering Charles Radding

ASBMB Today Staff
Jan. 4, 2021

Charles M. Radding, a professor emeritus of genetics at Yale University, died Oct. 20 at age 90. He was a member of the American Society for Biochemistry and Molecular Biology for 40 years.

Born June 8, 1930, in Springfield, Massachusetts, Radding earned an MD from Harvard Medical School in 1956. He served a medical internship in Boston and a research fellowship at the National Institutes of Health before conducting postdoctoral research at Stanford University with Arthur Kornberg, who won the Nobel Prize in physiology or medicine in 1959, the year Radding joined his lab. Radding joined the faculty at the University of Michigan before moving to Yale in 1967.

Charles Radding

In his lab, Radding characterized cellular proteins that mediate DNA recombination, focusing on the recA protein from E. coli. By purifying and studying proteins, he was able to reconstitute key steps of recombination in the lab. He and his colleague Matthew Meselson of Harvard formulated the articulation of a new general model of recombination, known as the Meselson–Radding Model.

Radding was elected into the National Academy of Sciences in 1995 and served for many years as an editor of the journal Proceedings of the National Academy of Sciences.

According to a Yale School of Medicine profile, Radding is remembered as an outstanding teacher, engaging lecturer, and dedicated and inspiring mentor: “He often accessorized his lectures with props: long rubber tubes representing DNA strands to illustrate difficult-to-visualize concepts like positive and negative DNA supercoiling and DNA strand exchange. Occasionally, the tubing got into a hopeless tangle, to the great amusement of the class!”

His interests outside the lab included classical music, literature, fine food, and languages, with a special fondness for French, the profile states, and “he was always happy with little urging to speak French, or, for that matter, any of a series of ersatz languages and accents that sounded surprisingly authentic.”

Radding is survived by his wife of more than 65 years, Natalie, as well as three daughters and a grandson.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

In memoriam: David Baltimore
Courtney Chandler
In memoriam: Stuart A. Kornfeld
Jeyashree Alagarsamy
2025 PROLAB awardees announced
Marissa Locke Rottinghaus

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Alan G. Goodridge
In Memoriam

In memoriam: Alan G. Goodridge

Dec. 9, 2025

He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
Member News

Alrubaye wins research and teaching awards

Dec. 8, 2025

He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.

Bibel named assistant professor
Member News

Bibel named assistant professor

Nov. 24, 2025

She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.